Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study

Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study

Histamine-2-receptor antagonist (H2RA) has shown beneficial effects on the kidney, heart, and sepsis in animal models and on the heart and COVID-19 infection in clinical studies. However, H2RAshave been used as a reference in most epidemiological studies examining the association of proton pump inhi...

Full description

Bibliographic Details
Main Authors:	Yi-Chun Chen, Yen-Chun Chen, Wen-Yen Chiou, Ben-Hui Yu
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Journal of Clinical Medicine
Subjects:	histamine-2-receptor antagonist proton pump inhibitor dose-response relationship CKD ESRD mortality
Online Access:	https://www.mdpi.com/2077-0383/11/19/5612

Similar Items

Drug–Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. <i>J. Clin. Med.</i> 2022, <i>11</i>, 5612
by: Ai-Hsien Li, et al.
Published: (2022-12-01)

Effects of Surgical Treatment for Obstructive Sleep Apnea on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study
by: Juen-Haur Hwang, et al.
Published: (2022-07-01)

Dose- and time-dependent renoprotection of Angelica sinensis in patients with chronic kidney disease: A longitudinal cohort study
by: Hsiao-Tien Chen, et al.
Published: (2023-04-01)

Assessment of puberty in children with chronic kidney disease and end-stage renal disease undergoing hemodialysis
by: Emad E. Ghobrial, et al.
Published: (2022-12-01)

The association between COPD and outcomes of patients with advanced chronic kidney disease
by: Lai CC, et al.
Published: (2018-09-01)

Acid Suppressive Drugs
by: Cheol Min Shin
Published: (2022-06-01)

Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs
by: Amanda Kuhl, et al.
Published: (2020-03-01)

Prediction of Ventilator-Associated Pneumonia in Patients Undergoing Stress Ulcer Prophylaxis: A Longitudinal Descriptive Study in Iran
by: Shahriar Nikpour, et al.
Published: (2020-11-01)

Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study
by: Paula F. Orlandi, et al.
Published: (2018-06-01)

Indication of acid suppression therapy and predictors for the prophylactic use of proton-pump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital
by: Oh AL, et al.
Published: (2015-09-01)

Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies
by: Jiangbi Li, et al.
Published: (2021-08-01)

Impact of proton pump inhibitor management committee’s multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments
by: Lu Liu, et al.
Published: (2022-03-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

The combined use of anti-peptic agents is associated with an increased risk of osteoporotic fracture: a nationwide case-control study
by: Dong Jun Oh, et al.
Published: (2024-03-01)

History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs
by: Dong Han Yeom, et al.
Published: (2023-09-01)

The prevalence and risk factors of kidney disease in first degree relatives of patients with ESRD treatment – single center study
by: Rabeea Abbas, et al.
Published: (2023-11-01)

Assessment of the Relationship Between Gastric-Acid Suppressants and the Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis
by: Karamali Kasiri, Associate, et al.
Published: (2023-01-01)

Editorial: Molecular Mechanisms in Chronic Kidney Disease
by: Claudia Torino, et al.
Published: (2021-06-01)

Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil
by: Helena Maciel-Guerra, et al.
Published: (2018-03-01)

Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update
by: Yung-Ming Chen, et al.
Published: (2017-11-01)

Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study
by: Yue Zhou, et al.
Published: (2021-05-01)

Comorbidity Profiles among Obese–Diabetic End-Stage Renal Disease Patients: Data from REIN Registry of PACA Region of France
by: Kakar A, et al.
Published: (2021-02-01)

<i>MIF rs755622</i> and <i>IL6 rs1800795</i> Are Implied in Genetic Susceptibility to End-Stage Renal Disease (ESRD)
by: Marco Guarneri, et al.
Published: (2022-01-01)

Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients
by: Akiomi Yoshihisa, et al.
Published: (2017-05-01)

Algorithm for pharmacists from community pharmacies who dispense over-the-counter proton pump inhibitors and histamine receptor antagonists for patients reporting symptoms of reflux
by: Elżbieta Jaworska, et al.
Published: (2024-01-01)

Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients
by: Juntao Xie, et al.
Published: (2022-07-01)

Corrigendum: Pre-existing proton pump inhibitor treatment and short-term prognosis of acute myocardial infarction patients
by: Juntao Xie, et al.
Published: (2022-07-01)

Renal and survival benefits of seventeen prescribed Chinese herbal medicines against oxidative-inflammatory stress in systemic lupus erythematosus patients with chronic kidney disease: a real-world longitudinal study
by: Hsiao-Tien Chen, et al.
Published: (2024-01-01)

The challenge of managing mild to moderate distress in patients with end stage renal disease: results from a multi-centre, mixed methods research study and the implications for renal service organisation
by: Sarah Damery, et al.
Published: (2019-12-01)

Prediction of Mortality in Patients on Peritoneal Dialysis Based on the Fibrinogen Mannosylation
by: Marko Baralić, et al.
Published: (2023-01-01)

Impact of Obesity in Kidney Diseases
by: Vasilios Kotsis, et al.
Published: (2021-12-01)

Association between the risk of heart failure hospitalization and end-stage renal disease with digoxin usage in patients with cardiorenal syndrome: A population-based study
by: Kai-Ting Chang, et al.
Published: (2023-01-01)

Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine
by: Ildikó Fritz, et al.
Published: (2021-04-01)

HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT
by: Schlioma ZATERKA, et al.

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
by: Xiaoyang Zhou, et al.
Published: (2019-11-01)

Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients
by: Yi-Ting Lin, et al.
Published: (2021-01-01)

Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis
by: Biswas Sangita, et al.
Published: (2012-06-01)

Comparative effectiveness of erythropoietin alpha and beta in hemodialysis patients: a single-center prospective observational study
by: Muhammad Nadeem Ahsan, et al.
Published: (2021-11-01)

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis
by: Xin Jiang, et al.
Published: (2019-09-01)

DNA Methylation Dysfunction in Chronic Kidney Disease
by: Diego Ingrosso, et al.
Published: (2020-07-01)